(+)-catechin multiple interactions ISO RGD:1322394 6480464 Catechin inhibits the reaction [Glucose results in increased expression of PCK2 protein] CTD PMID:24262486 (1->4)-beta-D-glucan multiple interactions ISO RGD:1553662 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of PCK2 mRNA CTD PMID:36331819 1,2-dichloroethane increases expression ISO RGD:1553662 6480464 ethylene dichloride results in increased expression of PCK2 mRNA CTD PMID:28960355 1,2-dimethylhydrazine increases expression ISO RGD:1553662 6480464 1, 2-Dimethylhydrazine results in increased expression of PCK2 mRNA CTD PMID:22206623 1-nitropyrene increases expression ISO RGD:1322394 6480464 1-nitropyrene results in increased expression of PCK2 mRNA CTD PMID:19041380 17alpha-ethynylestradiol affects expression ISO RGD:1553662 6480464 Ethinyl Estradiol affects the expression of PCK2 mRNA CTD PMID:17555576 17beta-estradiol increases expression ISO RGD:1322394 6480464 Estradiol results in increased expression of PCK2 mRNA CTD PMID:15757668 17beta-estradiol multiple interactions ISO RGD:1322394 6480464 [Estradiol co-treated with TGFB1 protein] results in decreased expression of PCK2 mRNA CTD PMID:30165855 17beta-estradiol multiple interactions EXP 6480464 [bisphenol A co-treated with Estradiol] results in decreased expression of PCK2 mRNA CTD PMID:26496021 2,2',4,4'-Tetrabromodiphenyl ether increases expression ISO RGD:1322394 6480464 2 more ... CTD PMID:19095052 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of PCK2 mRNA CTD PMID:22298810 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1322394 6480464 [Endosulfan co-treated with Tetrachlorodibenzodioxin] results in decreased expression of PCK2 mRNA, [Tetrachlorodibenzodioxin co-treated with 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide] results in increased expression of PCK2 mRNA CTD PMID:26159488 , PMID:29704546 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1322394 6480464 Tetrachlorodibenzodioxin results in decreased expression of PCK2 mRNA, Tetrachlorodibenzodioxin results in decreased expression of PCK2 protein CTD PMID:20106945 more ... 2,4,6-trinitrotoluene affects expression EXP 6480464 Trinitrotoluene affects the expression of PCK2 mRNA CTD PMID:21346803 2,4-dibromophenyl 2,4,5-tribromophenyl ether increases expression ISO RGD:1322394 6480464 2 more ... CTD PMID:26705709 2-butoxyethanol increases expression ISO RGD:1553662 6480464 n-butoxyethanol results in increased expression of PCK2 mRNA CTD PMID:19812364 3,4-methylenedioxymethamphetamine increases expression ISO RGD:1553662 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in increased expression of PCK2 mRNA CTD PMID:26251327 3,4-methylenedioxymethamphetamine increases methylation ISO RGD:1553662 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in increased methylation of PCK2 promoter CTD PMID:26251327 3-chloropropane-1,2-diol increases expression EXP 6480464 alpha-Chlorohydrin results in increased expression of PCK2 protein CTD PMID:34915118 4,4'-sulfonyldiphenol decreases expression ISO RGD:1322394 6480464 bis(4-hydroxyphenyl)sulfone results in decreased expression of PCK2 protein CTD PMID:31945527 4,4'-sulfonyldiphenol multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of PCK2 mRNA CTD PMID:36041667 5-aza-2'-deoxycytidine affects expression ISO RGD:1322394 6480464 Decitabine affects the expression of PCK2 mRNA CTD PMID:23300844 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of PCK2 mRNA CTD PMID:24780913 aflatoxin B1 decreases expression ISO RGD:1553662 6480464 Aflatoxin B1 results in decreased expression of PCK2 mRNA CTD PMID:19770486 aflatoxin B1 decreases expression ISO RGD:1322394 6480464 Aflatoxin B1 results in decreased expression of PCK2 mRNA CTD PMID:21632981 more ... aflatoxin B1 affects expression ISO RGD:1322394 6480464 Aflatoxin B1 affects the expression of PCK2 protein CTD PMID:20106945 aldehydo-D-glucose multiple interactions ISO RGD:1322394 6480464 Catechin inhibits the reaction [Glucose results in increased expression of PCK2 protein], Plant Extracts inhibits the reaction [Glucose results in increased expression of PCK2 protein] CTD PMID:24262486 aldehydo-D-glucose increases expression ISO RGD:1322394 6480464 Glucose results in increased expression of PCK2 protein CTD PMID:24262486 all-trans-retinoic acid decreases expression ISO RGD:1322394 6480464 Tretinoin results in decreased expression of PCK2 protein CTD PMID:15894607 amiodarone increases expression ISO RGD:1553662 6480464 Amiodarone results in increased expression of PCK2 mRNA CTD PMID:24489787 antirheumatic drug decreases expression ISO RGD:1322394 6480464 Antirheumatic Agents results in decreased expression of PCK2 mRNA CTD PMID:24449571 arsenite(3-) multiple interactions ISO RGD:1322394 6480464 arsenite promotes the reaction [G3BP1 protein binds to PCK2 mRNA] CTD PMID:32406909 arsenous acid decreases expression ISO RGD:1322394 6480464 Arsenic Trioxide results in decreased expression of PCK2 protein CTD PMID:19364129 atrazine increases expression EXP 6480464 Atrazine results in increased expression of PCK2 mRNA CTD PMID:27114639 atrazine increases expression ISO RGD:1322394 6480464 Atrazine results in increased expression of PCK2 mRNA CTD PMID:22378314 atrazine decreases expression ISO RGD:1322394 6480464 Atrazine results in decreased expression of PCK2 mRNA CTD PMID:27114639 avobenzone decreases expression ISO RGD:1322394 6480464 avobenzone results in decreased expression of PCK2 mRNA CTD PMID:31016361 benzo[a]pyrene decreases expression ISO RGD:1553662 6480464 Benzo(a)pyrene results in decreased expression of PCK2 mRNA CTD PMID:19770486 benzo[a]pyrene affects methylation ISO RGD:1322394 6480464 Benzo(a)pyrene affects the methylation of PCK2 promoter CTD PMID:27901495 benzo[a]pyrene multiple interactions ISO RGD:1322394 6480464 [Benzo(a)pyrene co-treated with benzo(b)fluoranthene] affects the expression of PCK2 mRNA CTD PMID:17690111 benzo[a]pyrene decreases expression ISO RGD:1322394 6480464 Benzo(a)pyrene results in decreased expression of PCK2 mRNA, Benzo(a)pyrene results in decreased expression of PCK2 protein CTD PMID:20106945 more ... benzo[b]fluoranthene multiple interactions ISO RGD:1322394 6480464 [Benzo(a)pyrene co-treated with benzo(b)fluoranthene] affects the expression of PCK2 mRNA CTD PMID:17690111 bisphenol A increases expression ISO RGD:1553662 6480464 bisphenol A results in increased expression of PCK2 mRNA CTD PMID:25270620 , PMID:33221593 bisphenol A decreases expression ISO RGD:1322394 6480464 bisphenol A results in decreased expression of PCK2 mRNA CTD PMID:31121516 bisphenol A affects expression ISO RGD:1322394 6480464 bisphenol A affects the expression of PCK2 mRNA CTD PMID:30903817 bisphenol A increases expression ISO RGD:1322394 6480464 bisphenol A results in increased expression of PCK2 mRNA CTD PMID:29275510 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of PCK2 mRNA CTD PMID:25181051 more ... bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of PCK2 mRNA, [bisphenol A co-treated with Estradiol] results in decreased expression of PCK2 mRNA CTD PMID:26496021 , PMID:36041667 Bisphenol B increases expression ISO RGD:1322394 6480464 bisphenol B results in increased expression of PCK2 protein CTD PMID:34186270 bisphenol F multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of PCK2 mRNA CTD PMID:36041667 bisphenol F increases expression ISO RGD:1322394 6480464 bisphenol F results in increased expression of PCK2 protein CTD PMID:34186270 bosentan decreases expression ISO RGD:1322394 6480464 Bosentan results in decreased expression of PCK2 mRNA CTD PMID:29761207 butan-1-ol multiple interactions ISO RGD:1322394 6480464 [[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of PCK2 mRNA CTD PMID:29432896 cadmium dichloride increases expression EXP 6480464 Cadmium Chloride results in increased expression of PCK2 mRNA CTD PMID:25993096 caffeine decreases phosphorylation ISO RGD:1322394 6480464 Caffeine results in decreased phosphorylation of PCK2 protein CTD PMID:35688186 cannabidiol multiple interactions ISO RGD:1322394 6480464 [Cannabidiol co-treated with moringin] results in decreased expression of PCK2 mRNA CTD PMID:30096889 carbamazepine affects expression ISO RGD:1322394 6480464 Carbamazepine affects the expression of PCK2 mRNA CTD PMID:25979313 chlorpyrifos increases expression ISO RGD:1553662 6480464 Chlorpyrifos results in increased expression of PCK2 mRNA CTD PMID:34289071 choline multiple interactions ISO RGD:1553662 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of PCK2 mRNA CTD PMID:20938992 cisplatin affects expression ISO RGD:1322394 6480464 Cisplatin affects the expression of PCK2 mRNA CTD PMID:23300844 cisplatin multiple interactions ISO RGD:1322394 6480464 [Cisplatin co-treated with jinfukang] results in increased expression of PCK2 mRNA CTD PMID:27392435 cisplatin increases expression ISO RGD:1322394 6480464 Cisplatin results in increased expression of PCK2 mRNA CTD PMID:27594783 clofibric acid affects expression EXP 6480464 Clofibric Acid affects the expression of PCK2 mRNA CTD PMID:17602206 clozapine decreases expression ISO RGD:1322394 6480464 Clozapine results in decreased expression of PCK2 protein CTD PMID:34122009 copper atom multiple interactions ISO RGD:1322394 6480464 [Chelating Agents binds to Copper] which results in increased expression of PCK2 mRNA more ... CTD PMID:20971185 more ... copper(0) multiple interactions ISO RGD:1322394 6480464 [Chelating Agents binds to Copper] which results in increased expression of PCK2 mRNA more ... CTD PMID:20971185 more ... copper(II) sulfate affects expression ISO RGD:1322394 6480464 Copper Sulfate affects the expression of PCK2 mRNA CTD PMID:19549813 corticosterone decreases expression EXP 6480464 Corticosterone results in decreased expression of PCK2 mRNA CTD PMID:15755911 coumarin increases expression EXP 6480464 coumarin results in increased expression of PCK2 mRNA CTD PMID:18480146 coumestrol increases expression ISO RGD:1322394 6480464 Coumestrol results in increased expression of PCK2 mRNA CTD PMID:19167446 coumestrol multiple interactions ISO RGD:1322394 6480464 [Coumestrol co-treated with 2, 3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PCK2 mRNA CTD PMID:19167446 crocidolite asbestos increases expression ISO RGD:1553662 6480464 Asbestos, Crocidolite results in increased expression of PCK2 mRNA CTD PMID:19446018 cyclosporin A increases expression ISO RGD:1322394 6480464 Cyclosporine results in increased expression of PCK2 mRNA CTD PMID:21632981 more ... cyclosporin A affects expression ISO RGD:1322394 6480464 Cyclosporine affects the expression of PCK2 mRNA CTD PMID:20106945 , PMID:25562108 D-glucose multiple interactions ISO RGD:1322394 6480464 Catechin inhibits the reaction [Glucose results in increased expression of PCK2 protein], Plant Extracts inhibits the reaction [Glucose results in increased expression of PCK2 protein] CTD PMID:24262486 D-glucose increases expression ISO RGD:1322394 6480464 Glucose results in increased expression of PCK2 protein CTD PMID:24262486 deoxynivalenol decreases expression ISO RGD:1322394 6480464 deoxynivalenol results in decreased expression of PCK2 mRNA CTD PMID:31863870 diarsenic trioxide decreases expression ISO RGD:1322394 6480464 Arsenic Trioxide results in decreased expression of PCK2 protein CTD PMID:19364129 dibutyl phthalate decreases expression EXP 6480464 Dibutyl Phthalate results in decreased expression of PCK2 mRNA CTD PMID:21266533 dibutyl phthalate increases expression ISO RGD:1322394 6480464 Dibutyl Phthalate results in increased expression of PCK2 mRNA CTD PMID:28973377 diclofenac decreases expression ISO RGD:1553662 6480464 Diclofenac results in decreased expression of PCK2 mRNA CTD PMID:35537566 disodium selenite increases expression ISO RGD:1322394 6480464 Sodium Selenite results in increased expression of PCK2 mRNA CTD PMID:24383545 disulfiram multiple interactions ISO RGD:1322394 6480464 [Disulfiram binds to Copper] which results in increased expression of PCK2 mRNA CTD PMID:24690739 endosulfan multiple interactions ISO RGD:1322394 6480464 [Endosulfan co-treated with Tetrachlorodibenzodioxin] results in decreased expression of PCK2 mRNA CTD PMID:26159488 endosulfan decreases expression ISO RGD:1322394 6480464 Endosulfan results in decreased expression of PCK2 mRNA, Endosulfan results in decreased expression of PCK2 protein CTD PMID:31520823 enniatin increases expression ISO RGD:1322394 6480464 enniatins results in increased expression of PCK2 mRNA CTD PMID:36016515 Enterolactone multiple interactions ISO RGD:1322394 6480464 [Coumestrol co-treated with 2, 3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PCK2 mRNA CTD PMID:19167446 ethanol multiple interactions ISO RGD:1322394 6480464 [[Gasoline co-treated with Ethanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of PCK2 mRNA, [Ethanol co-treated with Folic Acid] results in decreased expression of PCK2 mRNA CTD PMID:23378141 , PMID:29432896 etoposide decreases expression ISO RGD:1553662 6480464 Etoposide results in decreased expression of PCK2 mRNA CTD PMID:25270620 fenamidone increases expression ISO RGD:1553662 6480464 fenamidone results in increased expression of PCK2 mRNA CTD PMID:27029645 fenofibrate increases expression ISO RGD:1322394 6480464 Fenofibrate results in increased expression of PCK2 mRNA CTD PMID:16569247 , PMID:24752549 fipronil increases expression EXP 6480464 fipronil results in increased expression of PCK2 mRNA CTD PMID:31881178 flutamide increases expression EXP 6480464 Flutamide results in increased expression of PCK2 mRNA CTD PMID:21525395 , PMID:24136188 flutamide decreases expression EXP 6480464 Flutamide results in decreased expression of PCK2 mRNA CTD PMID:24793618 folic acid multiple interactions ISO RGD:1553662 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of PCK2 mRNA CTD PMID:20938992 folic acid multiple interactions ISO RGD:1322394 6480464 [Ethanol co-treated with Folic Acid] results in decreased expression of PCK2 mRNA CTD PMID:23378141 formaldehyde increases expression ISO RGD:1322394 6480464 Formaldehyde results in increased expression of PCK2 mRNA CTD PMID:27664576 gallic acid increases expression ISO RGD:1322394 6480464 Gallic Acid results in increased expression of PCK2 mRNA CTD PMID:34408198 genistein increases expression ISO RGD:1322394 6480464 Genistein results in increased expression of PCK2 mRNA CTD PMID:15757668 , PMID:26865667 gentamycin decreases expression EXP 6480464 Gentamicins results in decreased expression of PCK2 mRNA CTD PMID:22061828 glafenine increases expression EXP 6480464 Glafenine results in increased expression of PCK2 mRNA CTD PMID:24136188 glucose multiple interactions ISO RGD:1322394 6480464 Catechin inhibits the reaction [Glucose results in increased expression of PCK2 protein], Plant Extracts inhibits the reaction [Glucose results in increased expression of PCK2 protein] CTD PMID:24262486 glucose increases expression ISO RGD:1322394 6480464 Glucose results in increased expression of PCK2 protein CTD PMID:24262486 hydroquinone increases expression ISO RGD:1322394 6480464 hydroquinone results in increased expression of PCK2 mRNA CTD PMID:31256213 imidacloprid increases expression ISO RGD:1553662 6480464 imidacloprid results in increased expression of PCK2 mRNA CTD PMID:27960282 imidacloprid multiple interactions ISO RGD:1553662 6480464 Dietary Fats promotes the reaction [imidacloprid results in increased expression of PCK2 mRNA], imidacloprid promotes the reaction [Dietary Fats results in increased expression of PCK2 mRNA] CTD PMID:27960282 ivermectin decreases expression ISO RGD:1322394 6480464 Ivermectin results in decreased expression of PCK2 protein CTD PMID:32959892 L-ascorbic acid decreases expression ISO RGD:1322394 6480464 Ascorbic Acid results in decreased expression of PCK2 mRNA CTD PMID:19197388 L-methionine multiple interactions ISO RGD:1553662 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of PCK2 mRNA CTD PMID:20938992 lamivudine multiple interactions ISO RGD:1322394 6480464 [Zidovudine co-treated with Lamivudine] results in increased expression of PCK2 mRNA CTD PMID:15784690 lead diacetate increases expression ISO RGD:1553662 6480464 lead acetate results in increased expression of PCK2 mRNA CTD PMID:25270620 linalool increases expression ISO RGD:1322394 6480464 linalool results in increased expression of PCK2 mRNA CTD PMID:24752549 methapyrilene increases expression EXP 6480464 Methapyrilene results in increased expression of PCK2 mRNA CTD PMID:22484513 mono(2-ethylhexyl) phthalate increases expression ISO RGD:1322394 6480464 mono-(2-ethylhexyl)phthalate results in increased expression of PCK2 protein CTD PMID:31228551 N-methyl-4-phenylpyridinium increases expression ISO RGD:1322394 6480464 1-Methyl-4-phenylpyridinium results in increased expression of PCK2 mRNA CTD PMID:24810058 N-methyl-4-phenylpyridinium increases expression EXP 6480464 1-Methyl-4-phenylpyridinium results in increased expression of PCK2 mRNA CTD PMID:28801915 N-nitrosodiethylamine decreases expression ISO RGD:1322394 6480464 Diethylnitrosamine results in decreased expression of PCK2 mRNA CTD PMID:21527772 N-nitrosodiethylamine increases expression ISO RGD:1553662 6480464 Diethylnitrosamine results in increased expression of PCK2 mRNA CTD PMID:24535843 O-methyleugenol decreases expression ISO RGD:1322394 6480464 methyleugenol results in decreased expression of PCK2 mRNA CTD PMID:32234424 ochratoxin A decreases expression ISO RGD:1322394 6480464 ochratoxin A results in decreased expression of PCK2 mRNA CTD PMID:19287073 Octicizer multiple interactions ISO RGD:1553662 6480464 [tris(2-butoxyethyl) phosphate co-treated with IMOL S-140 co-treated with tri-(2-chloroisopropyl)phosphate co-treated with tris(1, 3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with santicizer 148 co-treated with tris(chloroethyl)phosphate co-treated with 2-ethylhexyldiphenylphosphate co-treated with tributyl phosphate] results in increased expression of PCK2 mRNA CTD PMID:33367866 oxaliplatin decreases expression EXP 6480464 oxaliplatin results in decreased expression of PCK2 mRNA CTD PMID:25729387 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of PCK2 mRNA CTD PMID:25729387 oxaliplatin decreases expression ISO RGD:1322394 6480464 oxaliplatin results in decreased expression of PCK2 mRNA CTD PMID:17762391 ozone multiple interactions ISO RGD:1553662 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of PCK2 mRNA CTD PMID:34911549 p-toluidine increases expression EXP 6480464 4-toluidine results in increased expression of PCK2 mRNA CTD PMID:27638505 paracetamol affects expression ISO RGD:1553662 6480464 Acetaminophen affects the expression of PCK2 mRNA CTD PMID:17562736 paracetamol affects expression ISO RGD:1322394 6480464 Acetaminophen affects the expression of PCK2 mRNA CTD PMID:25704631 perfluorobutanesulfonic acid increases expression ISO RGD:1322394 6480464 perfluorobutanesulfonic acid results in increased expression of PCK2 mRNA CTD PMID:35337807 perfluorodecanoic acid increases expression ISO RGD:1322394 6480464 perfluorodecanoic acid results in increased expression of PCK2 mRNA CTD PMID:35337807 perfluorododecanoic acid increases expression ISO RGD:1322394 6480464 perfluorododecanoic acid results in increased expression of PCK2 mRNA CTD PMID:35337807 perfluoroheptanoic acid increases expression ISO RGD:1322394 6480464 perfluoro-n-heptanoic acid results in increased expression of PCK2 mRNA CTD PMID:35337807 perfluorohexanesulfonic acid increases expression ISO RGD:1322394 6480464 perfluorohexanesulfonic acid results in increased expression of PCK2 mRNA CTD PMID:35337807 perfluorohexanoic acid increases expression ISO RGD:1322394 6480464 perfluorohexanoic acid results in increased expression of PCK2 mRNA CTD PMID:35337807 perfluorononanoic acid increases expression ISO RGD:1322394 6480464 perfluoro-n-nonanoic acid results in increased expression of PCK2 mRNA CTD PMID:32588087 perfluorooctane-1-sulfonic acid increases expression ISO RGD:1322394 6480464 perfluorooctane sulfonic acid results in increased expression of PCK2 mRNA CTD PMID:21723365 perfluorooctane-1-sulfonic acid multiple interactions ISO RGD:1553662 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of PCK2 mRNA CTD PMID:36331819 perfluorooctanesulfonamide increases expression ISO RGD:1322394 6480464 perfluorooctanesulfonamide analog results in increased expression of PCK2 mRNA CTD PMID:35337807 perfluorooctanoic acid increases expression EXP 6480464 perfluorooctanoic acid results in increased expression of PCK2 mRNA CTD PMID:21723365 perfluorooctanoic acid increases expression ISO RGD:1322394 6480464 perfluorooctanoic acid results in increased expression of PCK2 mRNA CTD PMID:21723365 perfluoropentanoic acid increases expression ISO RGD:1322394 6480464 perfluoropentanoic acid results in increased expression of PCK2 mRNA CTD PMID:35337807 perfluoroundecanoic acid increases expression ISO RGD:1322394 6480464 perfluoroundecanoic acid results in increased expression of PCK2 mRNA CTD PMID:35337807 progesterone increases expression ISO RGD:1322394 6480464 Progesterone results in increased expression of PCK2 mRNA CTD PMID:21795739 prothioconazole increases expression ISO RGD:1322394 6480464 prothioconazole results in increased expression of PCK2 mRNA CTD PMID:35048155 resveratrol increases expression ISO RGD:1553662 6480464 resveratrol results in increased expression of PCK2 protein CTD PMID:25505154 S-(1,2-dichlorovinyl)-L-cysteine increases expression ISO RGD:1322394 6480464 S-(1, 2-dichlorovinyl)cysteine results in increased expression of PCK2 mRNA CTD PMID:33725128 selenomethionine affects expression ISO RGD:1322394 6480464 Selenomethionine affects the expression of PCK2 mRNA CTD PMID:17222674 silicon dioxide decreases expression ISO RGD:1322394 6480464 Silicon Dioxide analog results in decreased expression of PCK2 mRNA CTD PMID:23806026 silver atom increases expression ISO RGD:1322394 6480464 Silver analog results in increased expression of PCK2 mRNA CTD PMID:24974767 silver(0) increases expression ISO RGD:1322394 6480464 Silver analog results in increased expression of PCK2 mRNA CTD PMID:24974767 sodium arsenite decreases expression ISO RGD:1322394 6480464 sodium arsenite results in decreased expression of PCK2 mRNA, sodium arsenite results in decreased expression of PCK2 protein CTD PMID:24866292 more ... sodium dodecyl sulfate decreases expression ISO RGD:1322394 6480464 Sodium Dodecyl Sulfate results in decreased expression of PCK2 mRNA CTD PMID:31734321 sodium fluoride decreases expression ISO RGD:1553662 6480464 Sodium Fluoride results in decreased expression of PCK2 protein CTD PMID:28918527 sulfluramid increases expression ISO RGD:1322394 6480464 sulfluramid results in increased expression of PCK2 mRNA CTD PMID:35337807 sulforaphane increases expression ISO RGD:1322394 6480464 sulforaphane results in increased expression of PCK2 mRNA CTD PMID:31838189 sulindac increases expression ISO RGD:1322394 6480464 Sulindac results in increased expression of PCK2 mRNA CTD PMID:11906190 sunitinib increases expression ISO RGD:1322394 6480464 Sunitinib results in increased expression of PCK2 mRNA CTD PMID:31533062 T-2 toxin decreases expression ISO RGD:1322394 6480464 T-2 Toxin results in decreased expression of PCK2 mRNA CTD PMID:31863870 tamoxifen affects expression ISO RGD:1553662 6480464 Tamoxifen affects the expression of PCK2 mRNA CTD PMID:17555576 temozolomide increases expression ISO RGD:1322394 6480464 Temozolomide results in increased expression of PCK2 mRNA CTD PMID:31758290 tetrachloroethene increases expression ISO RGD:1553662 6480464 Tetrachloroethylene results in increased expression of PCK2 mRNA CTD PMID:28973375 tetrachloromethane affects expression ISO RGD:1553662 6480464 Carbon Tetrachloride affects the expression of PCK2 mRNA CTD PMID:17484886 thapsigargin increases expression ISO RGD:1322394 6480464 Thapsigargin results in increased expression of PCK2 mRNA CTD PMID:21694771 , PMID:22378314 thapsigargin decreases expression ISO RGD:1322394 6480464 Thapsigargin results in decreased expression of PCK2 mRNA CTD PMID:22378314 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of PCK2 mRNA CTD PMID:25729387 topotecan decreases expression EXP 6480464 Topotecan results in decreased expression of PCK2 mRNA CTD PMID:25729387 tributyl phosphate multiple interactions ISO RGD:1553662 6480464 [tris(2-butoxyethyl) phosphate co-treated with IMOL S-140 co-treated with tri-(2-chloroisopropyl)phosphate co-treated with tris(1, 3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with santicizer 148 co-treated with tris(chloroethyl)phosphate co-treated with 2-ethylhexyldiphenylphosphate co-treated with tributyl phosphate] results in increased expression of PCK2 mRNA CTD PMID:33367866 tributylstannane increases expression ISO RGD:1553662 6480464 tributyltin results in increased expression of PCK2 protein CTD PMID:31306684 Tributyltin oxide increases expression ISO RGD:1553662 6480464 bis(tri-n-butyltin)oxide results in increased expression of PCK2 mRNA CTD PMID:25270620 triphenyl phosphate increases expression EXP 6480464 triphenyl phosphate results in increased expression of PCK2 mRNA CTD PMID:30589522 triphenyl phosphate multiple interactions ISO RGD:1553662 6480464 [tris(2-butoxyethyl) phosphate co-treated with IMOL S-140 co-treated with tri-(2-chloroisopropyl)phosphate co-treated with tris(1, 3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with santicizer 148 co-treated with tris(chloroethyl)phosphate co-treated with 2-ethylhexyldiphenylphosphate co-treated with tributyl phosphate] results in increased expression of PCK2 mRNA CTD PMID:33367866 tris(2-butoxyethyl) phosphate affects expression ISO RGD:1322394 6480464 tris(2-butoxyethyl) phosphate affects the expression of PCK2 mRNA CTD PMID:29024780 tris(2-butoxyethyl) phosphate multiple interactions ISO RGD:1553662 6480464 [tris(2-butoxyethyl) phosphate co-treated with IMOL S-140 co-treated with tri-(2-chloroisopropyl)phosphate co-treated with tris(1, 3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with santicizer 148 co-treated with tris(chloroethyl)phosphate co-treated with 2-ethylhexyldiphenylphosphate co-treated with tributyl phosphate] results in increased expression of PCK2 mRNA CTD PMID:33367866 tris(2-chloroethyl) phosphate multiple interactions ISO RGD:1553662 6480464 [tris(2-butoxyethyl) phosphate co-treated with IMOL S-140 co-treated with tri-(2-chloroisopropyl)phosphate co-treated with tris(1, 3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with santicizer 148 co-treated with tris(chloroethyl)phosphate co-treated with 2-ethylhexyldiphenylphosphate co-treated with tributyl phosphate] results in increased expression of PCK2 mRNA CTD PMID:33367866 troglitazone increases expression ISO RGD:1322394 6480464 troglitazone results in increased expression of PCK2 mRNA CTD PMID:20846491 troglitazone decreases expression ISO RGD:1322394 6480464 troglitazone results in decreased expression of PCK2 mRNA CTD PMID:25572481 trovafloxacin decreases expression ISO RGD:1553662 6480464 trovafloxacin results in decreased expression of PCK2 mRNA CTD PMID:35537566 tunicamycin increases expression ISO RGD:1322394 6480464 Tunicamycin results in increased expression of PCK2 mRNA CTD PMID:22378314 , PMID:29453283 tunicamycin decreases expression ISO RGD:1322394 6480464 Tunicamycin results in decreased expression of PCK2 mRNA CTD PMID:22378314 urethane decreases expression ISO RGD:1322394 6480464 Urethane results in decreased expression of PCK2 mRNA CTD PMID:28818685 valproic acid increases expression ISO RGD:1553662 6480464 Valproic Acid results in increased expression of PCK2 mRNA CTD PMID:24489787 valproic acid affects expression ISO RGD:1322394 6480464 Valproic Acid affects the expression of PCK2 mRNA CTD PMID:25979313 XL147 multiple interactions ISO RGD:1553662 6480464 XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of PCK2 mRNA] CTD PMID:29891994 zearalenone increases expression ISO RGD:1553662 6480464 Zearalenone results in increased expression of PCK2 protein CTD PMID:25058043 zidovudine multiple interactions ISO RGD:1322394 6480464 [Zidovudine co-treated with Lamivudine] results in increased expression of PCK2 mRNA CTD PMID:15784690
